DiaMedica Therapeutics Inc. (DMAC)

NCM – Real Time Price. Currency in USD

6.87

0.00 (0.00%)

Market open: Aug 12, 2026, 12:50 PM EDT

6.77

-0.10 (-1.46%)

Previous after-hours: Aug 11, 2026, 7:43 PM EDT

11.08.2026

DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript

11.08.2026

DiaMedica Therapeutics Q2 Earnings Call Highlights

DiaMedica Therapeutics NASDAQ: DMAC said its second-quarter progress centered on advancing DM199 across early-onset fetal growth restriction (FGR), preeclampsia and acute ischemic stroke, while the company reported a cash runway it expects to extend through 2027.

10.08.2026

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today provided a business update and reported financial results for the second quarter ended June 30, 2026. Management will host a conference call Tuesday, August 11, 2026, at 8:00 AM Eastern Time / 7:00 AM Central Time to discuss its business update and second quarter 202.

04.08.2026

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS), today announced that its second quarter 2026 financial results will be released after the markets close on Monday, August 10th. DiaMedica will host a live conference call on Tuesday, August 11th at 8:00 AM Eastern Time / 7:00 AM Central Time to provide a business upd.

Videos

No Data

There is no data to display

Press releases

10.08.2026

DiaMedica Therapeutics Inc. (DMAC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript

DiaMedica Therapeutics Q2 Earnings Call Highlights

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026

Videos

No Data

Press releases

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript

DiaMedica Therapeutics Q2 Earnings Call Highlights

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026

Videos

No Data

Press releases

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Search stocks

DiaMedica Therapeutics Inc. (DMAC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript

DiaMedica Therapeutics Q2 Earnings Call Highlights

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026

Videos

No Data

Press releases

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript

DiaMedica Therapeutics Q2 Earnings Call Highlights

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026

Videos

No Data

Press releases

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights